Comparison of the anti-allodynic and antinociceptive effects of systemic, intrathecal and intracerebroventricular morphine in a rat model of central neuropathic pain

European Journal of Pain

Volumn 1, Issue 1, 1997, Pages 17-29

  Yu, W ^a   Hao, J X ^a   Xu, X J ^a   Wiesenfeld Hallin, Z ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003163745     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(97)90049-5     Document Type: Article

References (42)

1. Advokat C, Gulati A. Spinal transection reduces both spinal antinociception and CNS concentration of systemically administered morphine in rats. Brain Res 1991; 555: 251-258.
2. Arnér S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988; 33: 11-23.
3. Arnér S, Meyerson B. Opioids in neuropathic pain. Pain Dig 1993; 3: 15-22.
4. Arvidsson U, Riedl M, Chakrabarti S, Lee J-H, Nakano AH, Dado RJ, Loh HH, Law P-Y, Wessendorf MW, Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 1995; 15: 3328-3341.
5. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Ann Rev Neurosci 1984; 7: 309-338.
6. Besse D, Lombard MC, Zagac JM, Roques BP, Besson JM. Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 1990; 521: 15-22.
7. Bian D, Nichols ML, Ossipov MH, Lai J, Porreca F. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. Neuro Report 1995; 6: 1981-1984.
8. Boivie J. Central pain. In: Wall PD, Melzack R, editors. Textbook of Pain. London: Churchill Livingstone, 1994: 871-892.
9. Borszcz G. Increases in vocalization and motor reflex thresholds are influenced by the site of morphine microinjection: comparisons following administration into the periaqueductal gray, ventral medulla, and spinal subarachnoid space. Behav Neurosci 1995; 109: 502-522.
10. Bowsher D, Nurmikko T. Central post-stroke pain - drug treatment options. CNS Drugs 1996; 5: 160-165.
11. Davar G, Hama A, Deykin A, Vos B, Macievicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res 1991; 553: 327-330.
12. Glynn C, Jamous MA, Teddy PJ, Moore RA, Lloyd JW. The role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury. Lancet 1996; ii: 1249-1250.
13. Glynn C, Dawson D, Sanders R. A double-blind comparison between epidural morphine and epidural clonidine in patients with chronic non-cancer pain. Pain 1988; 34: 123-128.
14. Hammond D. Intrathecal administration: methodological considerations. In: Fields HL, Besson JM, editors. Progress in Brain Research. Volume 77. Amsterdam: Elsevier, 1988: 313-320.
15. Hammond D. Do opioids relieve central pain. In: Casey KL, editor. Pain and Central Nervous System Disease: The Central Pain Syndromes. New York: Raven Press, 1991: 233-242.
16. Hao J-X, Yu W, Xu X-J, Wiesenfeld-Hallin Z. Capsaicin-sensitive afferents mediate chronic cold, but not mechanical, allodynia-like behavior in spinally injured rats. Brain Res 1996a; 196: 116-118.
17. Hao J-X, Yu W, Xu X-J, Wiesenfeld-Hallin Z. Treatment of chronic allodynia-like symptoms in rats after spinal cord injury: Systemic vs intrathecal clonidine. Brain Res 1996b; 736: 28-34.
18. Hayes RL, Price DD, Bennett GJ, Wilcox GL, Mayer DJ. Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of nociceptive reflexes: further evidence for the physiologic multiplicity of pain modulation. Brain Res 1978; 155: 91-101.
19. Herz A, Teschemacher H-J. Activities and sites of anti-nociceptive action of morphine-like analgesics. Adv Drug Res 1971; 6: 79-119.
20. Kupers RC, Konings H, Adriaemsen H, Gybels JM. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 1991; 47: 5-12.
21. Lee Y-W, Chaplan SR, Yaksh TL. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett 1995; 186: 111-114.
22. Levine J, Feldmesser M, Tecott L, Gordon N, Izdebski K. Pain-induced vocalization in the rat and its modification by pharmacological agents. Brain Res 1984; 296: 121-127.
23. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995a; 61: 353-64.
24. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995b; 62: 259-74.
25. McQuay HJ, Jadad AR, Carroll D, Faura C, Glynn CJ, Moore RA, Liu Y. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesiology 1992; 47: 757-767.
26. Nichols ML, Bian D, Ossipov MH, Lai J, Porreca F. Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J Pharmacol Exp Ther 1995; 275: 1399-1345.
27. Ossipov MH, Lopez Y, Nichols ML, Bian D, Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci Lett 1995; 199: 83-86.
28. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990; 43: 273-286.
29. Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM. I.V. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Res 1986; 70: 575-581.
30. Puke MJC, Wiesenfeld-Hallin Z. The differential effects of morphine and the α2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesth Analg 1993; 77: 104-109.
31. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of post-herpetic neuralgia. Neural 1991; 41: 1024-1028.
32. Storkson RV, Kjorsvik A, Tjolsen A, Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Meth 1996; 65: 167-172.
33. Wiesenfeld-Hallin Z, Hao J-X, Xu X-J, Hökfelt T. Nitric oxide mediates ongoing discharges in dorsal root ganglion cells after peripheral nerve injury. J Neurophysiol 1993; 70: 2350-2354.
34. Wiesenfeld-Hallin Z, Xu X-J. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance. Regul Pept 1996; 65: 23-28.
35. Xu X-J, Hao J-X, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain 1992; 48: 279-290.
36. Xu X-J, Puke MJC, Verge VMK, Wiesenfeld-Hallin Z, Hughes J, Hökfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain. Neurosci Lett 1993; 152: 129-132.
37. Xu X-J, Wiesenfeld-Hallin Z. The threshold for the depressive effect of intrathecal morphine on the spinal nociceptive flexor reflex is increased during autotomy after sciatic nerve section in rats. Pain 1991; 46: 223-229.
38. Yaksh TL. The spinal pharmacology of anomalous pain processing. In: Casey KL, editor. Pain and Central Nervous System Disease: The Central Pain Syndromes. New York: Raven Press, 1991: 243-256.
39. Yaksh TL, Rudy TA. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 1977; 202: 411-428.
40. Yamamoto T, Mizuguchi T. Time-dependent effects of oral morphine on autotomy following brachial nerve section in the rat. Neurosci Lett 1992; 141: 166-168.
41. Yamamoto T, Nozakitaguchi N. Role of cholecystokinin-B receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci Lett 1995; 202: 89-92.
42. Yeung JC, Rudy TA. Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J Pharmacol Exp Ther 1980; 215: 633-642.